ASND Competitors & Alternatives
Compare Ascendis Pharma AS with similar stocks in the same industry
Biotechnology
ASND
Main Stock$277.18
Tradestie Score
59
Market Cap
$12.36B
P/E Ratio
31.3
Revenue Growth
1.4%
Analyst Upside
+5.8%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BNTX
BioNTech SE American Depositary Share
|
$93.53
|
$24.57B | - | 56 | Compare |
|
GMAB
Genmab A/S ADS
|
$29.54
|
$19.56B | 21.3 | 57 | Compare |
|
INCY
Incyte Genomics Inc
|
$117.26
|
$16.93B | 16.4 | 62 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$58.37
|
$15.70B | 29.9 | 65 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.69
|
$15.22B | - | 52 | Compare |
|
EXEL
Exelixis Inc
|
$56.11
|
$11.09B | 18.9 | 66 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$36.09
|
$10.76B | - | 57 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$73.80
|
$10.74B | - | 60 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$59.75
|
$10.53B | 42.5 | 61 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$84.46
|
$10.49B | - | 66 | Compare |
More ASND Analysis
Data updated: Jul 08, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry